Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10072-025-08327-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Health Care Utilization and Costs in the Year Before and After Total Hip Arthroplasty.
J Arthroplasty
June 2025
Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania
Background: In the era of value-based care, cost-reduction strategies for total hip arthroplasty (THA) have focused on surgical bundles and reductions in postacute care spending. Few studies have evaluated the costs of nonoperative treatment and the impact of THA as a cost-saving measure for longitudinal spending. The purpose of this study was to determine the costs of care for THA patients in the year before and the year following THA.
View Article and Find Full Text PDFCost-efficacy evaluation of a mindfulness-based program added to treatment as usual for the treatment of chronic migraine associated to medication overuse headache.
Neurol Sci
June 2025
Neuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Clonidine for Management of Agitation in Delirious Patients.
Curr Psychiatry Rep
August 2025
Department of Psychiatry, University of Michigan, 4250 Plymouth Rd, Ann Arbor, MI, 48105, USA.
Purpose Of Review: This review explores clonidine as a potential treatment for agitation across various clinical contexts, focusing on its application in patients with limited cognitive reserve, hyperactive delirium, or conditions where standard treatments may exacerbate underlying symptoms, such as Parkinsonism. The review evaluates the pharmacological properties, efficacy, and practical considerations for using clonidine in managing agitation, including its role in other psychiatric and medical conditions.
Recent Findings: Clonidine, a centrally acting alpha-2 adrenergic agonist, reduces norepinephrine release, leading to sedation, anxiolysis, and analgesia without significant respiratory depression.
Should we be Prescribing Fluphenazine Long-Acting Injectable Formulation?
Curr Psychiatry Rep
June 2025
Department of Psychiatry, University of Michigan, 4250 Plymouth Rd, Ann Arbor, MI, 48105, US.
Purpose Of Review: This review critically examines the clinical utility, efficacy, and tolerability of fluphenazine long-acting injectable (LAI) relative to contemporary alternatives. It further evaluates whether fluphenazine LAI confers substantive advantages over other available formulations for the management of schizophrenia, particularly in light of its long-standing use.
Recent Findings: The extant literature demonstrates that the tolerability and side effect profile of fluphenazine LAI are comparable to other FGA LAIs but likely less favorable than available second-generation antipsychotic (SGA) LAIs.
An Analysis of Costs in the Year Before and After Total Knee Arthroplasty.
J Arthroplasty
July 2025
Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
Background: While insurance claims database studies have reported on costs before total knee arthroplasty (TKA), the cost-efficacy of nonoperative treatment remains unclear in patients who eventually undergo TKA. Furthermore, we hypothesized that patients undergoing primary TKA would have lower costs in the year following surgery than if patients continued nonoperative treatment. The purpose of this study was to determine the costs of various nonoperative treatment modalities in the year before and following primary TKA.
View Article and Find Full Text PDF